These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 35147634
41. The glucose-lowering effects of α-glucosidase inhibitor require a bile acid signal in mice. Qiu Y, Shen L, Fu L, Yang J, Cui C, Li T, Li X, Fu C, Gao X, Wang W, Ning G, Gu Y. Diabetologia; 2020 May; 63(5):1002-1016. PubMed ID: 32034442 [Abstract] [Full Text] [Related]
45. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal. Schmitt J, Kong B, Stieger B, Tschopp O, Schultze SM, Rau M, Weber A, Müllhaupt B, Guo GL, Geier A. Liver Int; 2015 Apr; 35(4):1133-1144. PubMed ID: 25156247 [Abstract] [Full Text] [Related]
47. Modulation of the Gut Microbiota-farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice. Xu M, Shen Y, Cen M, Zhu Y, Cheng F, Tang L, Zheng X, Kim JJ, Dai N, Hu W. J Crohns Colitis; 2021 Jul 05; 15(7):1197-1210. PubMed ID: 33417675 [Abstract] [Full Text] [Related]
51. Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity. Prawitt J, Abdelkarim M, Stroeve JH, Popescu I, Duez H, Velagapudi VR, Dumont J, Bouchaert E, van Dijk TH, Lucas A, Dorchies E, Daoudi M, Lestavel S, Gonzalez FJ, Oresic M, Cariou B, Kuipers F, Caron S, Staels B. Diabetes; 2011 Jul 29; 60(7):1861-71. PubMed ID: 21593203 [Abstract] [Full Text] [Related]
52. A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility. Wei M, Huang F, Zhao L, Zhang Y, Yang W, Wang S, Li M, Han X, Ge K, Qu C, Rajani C, Xie G, Zheng X, Zhao A, Bian Z, Jia W. EBioMedicine; 2020 May 29; 55():102766. PubMed ID: 32408110 [Abstract] [Full Text] [Related]
54. Role of bile acids and bile acid receptors in metabolic regulation. Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. Physiol Rev; 2009 Jan 29; 89(1):147-91. PubMed ID: 19126757 [Abstract] [Full Text] [Related]
56. Dietary bile acids reduce liver lipid deposition via activating farnesoid X receptor, and improve gut health by regulating gut microbiota in Chinese perch (Siniperca chuatsi). Zhang Y, Feng H, Liang XF, He S, Lan J, Li L. Fish Shellfish Immunol; 2022 Feb 29; 121():265-275. PubMed ID: 35026410 [Abstract] [Full Text] [Related]
57. Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice. Li Q, Li M, Li F, Zhou W, Dang Y, Zhang L, Ji G. J Ethnopharmacol; 2020 Aug 10; 258():112896. PubMed ID: 32325178 [Abstract] [Full Text] [Related]
58. Lactiplantibacillus plantarum H-87 prevents high-fat diet-induced obesity by regulating bile acid metabolism in C57BL/6J mice. Liang C, Zhou XH, Gong PM, Niu HY, Lyu LZ, Wu YF, Han X, Zhang LW. Food Funct; 2021 May 21; 12(10):4315-4324. PubMed ID: 34031676 [Abstract] [Full Text] [Related]
60. INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis. Roth JD, Feigh M, Veidal SS, Fensholdt LK, Rigbolt KT, Hansen HH, Chen LC, Petitjean M, Friley W, Vrang N, Jelsing J, Young M. World J Gastroenterol; 2018 Jan 14; 24(2):195-210. PubMed ID: 29375205 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]